J Woolf Eric
Merck & Co., Inc., Pharmacokinetics, Pharmacodynamics & Drug Metabolism, Regulated Bioanalysis, 770 Sumneytown Pike, WP75B-300, West Point, PA 19486, USA.
Bioanalysis. 2019 Aug;11(15):1387-1388. doi: 10.4155/bio-2019-0178.
Biography Dr Woolf is currently Executive Director of the regulated PK Bioanalysis Group of Merck Research Laboratories, West Point, PA, USA. He received his BA in Chemistry from LaSalle College in 1982, and a PhD in Analytical Chemistry from Seton Hall University in 1986. From 1986 to 1990, he was a member of the Drug Metabolism/Pharmacokinetics Department of Berlex Laboratories. He joined Merck Research Laboratories in 1990 as a research fellow. Dr Woolf and his group have supported numerous clinical development projects that have led to the successful registration of Merck compounds. Since 1986, he has authored or coauthored over 50 research papers pertaining to bioanalysis and pharmacokinetics. This interview was conducted by Sankeetha Nadarajah, Managing Commissioning Editor of at the AAPS ICH-M10 Public Consultation Workshop (Silver Spring, MD, USA), 11 June 2019.
个人简介 伍尔夫博士现任美国宾夕法尼亚州西点市默克研究实验室受监管的PK生物分析小组执行主任。他于1982年从拉萨尔学院获得化学学士学位,并于1986年从西顿霍尔大学获得分析化学博士学位。1986年至1990年,他是勃林格殷格翰实验室药物代谢/药代动力学部门的成员。1990年,他作为研究员加入默克研究实验室。伍尔夫博士及其团队支持了众多临床开发项目,这些项目促成了默克化合物的成功注册。自1986年以来,他撰写或共同撰写了50多篇有关生物分析和药代动力学的研究论文。本次采访由《 》的执行主编桑基莎·纳达拉贾于2019年6月11日在美国马里兰州银泉市举行的AAPS ICH-M10公众咨询研讨会上进行。